Technology license agreement - Additional Information (Details) - BWH License - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Sep. 15, 2020 |
Jan. 20, 2018 |
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Technology License Agreement [Line Items] | ||||
Committed amount to remitting in support of clinical trial | $ 800,000 | |||
Committed period to remitting in support of clinical trial | 3 years | |||
Non-refundable fee | $ 40,000 | |||
Expense for startup and patient fees for clinical trials | $ 0 | $ 0 | ||
Payment for license fee | $ 100,000 | |||
Payment at the time of entering into license | 100,000 | |||
Payment for annual license fee | 50,000 | |||
Maximum amount upon achievement of various clinical, commercial and sales milestones | $ 39,000,000.0 |